RJFSA
INSM icon

Raymond James Financial Services Advisors’s Insmed INSM Stock Holding History

Raymond James Financial Services Advisors’s Portfolio INSM Stock Details INSM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-41,337
Closed -$1.04M – 3362
2023
Q3 		$1.04M Buy
+41,337
New +$945K ﹤0.01% 1873
2019
Q2 		– Sell
-8,747
Closed -$254K – 2878
2019
Q1 		$254K Buy
+8,747
New +$227K ﹤0.01% 2354

Other funds holding INSM

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $724M AUM 96.91% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $23.2B AUM 40.19% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return

Raymond James Financial Services Advisors's INSM Position: Q4 2023 in Review

Raymond James Financial Services Advisors sold out of Insmed (INSM) in Q4 2023, closing a stake of 41,337 shares — an estimated $1.04M sold.

Raymond James Financial Services Advisors first reported a position in INSM in Q1 2019 and held it in 2 quarters. The position peaked at $1.04M in Q3 2023. 271 funds tracked by Wall St. Rank hold INSM as of Q4 2023.

  • Raymond James Financial Services Advisors reported no remaining Insmed position as of Q4 2023 after selling out during the quarter.
  • Raymond James Financial Services Advisors sold 41,337 Insmed shares in Q4 2023, an estimated $1.04M.
  • Raymond James Financial Services Advisors first reported a position in Insmed in Q1 2019 and held it in 2 quarters.
  • Raymond James Financial Services Advisors's Insmed position peaked at $1.04M in Q3 2023.
  • 271 funds tracked by Wall St. Rank held Insmed as of Q4 2023.

Based on Raymond James Financial Services Advisors's 13F filing for Q4 2023, filed 16 Jan 2024.